Neostem, Inc. (Amex:NBS) an international biopharmaceutical company with a focus on cell-based therapeutic development, announced that the Company and Progenitor Cell Therapy ("PCT"), will be presenting at four upcoming January conferences: Biotech Showcase 2012, BOCEMb 2012 - Noble Financial Capital Markets Equity Conference, ECI's Inaugural Scale-Up and Manufacturing of Cell-Based Therapies, and Phacilitate's Cell & Gene Therapy Forum 2012.

NeoStem, Inc., a biopharmaceutical company, engages in the development and manufacture of cellular therapies for oncology, immunology, and regenerative medicines in the United States and China.

Read the full article at: http://stockhottips.com/20053/top-news/nbs-gblhf-gst-drj-stock-updates-b...